Publications by authors named "Theodore G Karrison"

37Publications

Impact of TCR Diversity on the Development of Transplanted or Chemically Induced Tumors.

Cancer Immunol Res 2020 02 12;8(2):192-202. Epub 2019 Dec 12.

Institute of Immunology, Charité - Universitätsmedizin Berlin, Campus Buch, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-19-0567DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007920PMC
February 2020

Prolonged Pharmacokinetic Interaction Between Capecitabine and a CYP2C9 Substrate, Celecoxib.

J Clin Pharmacol 2019 12 5;59(12):1632-1640. Epub 2019 Jul 5.

Department of Medicine, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcph.1476DOI Listing
December 2019

Effects of driving distance and transport time on mortality among Level I and II traumas occurring in a metropolitan area.

J Trauma Acute Care Surg 2018 Oct;85(4):756-765

From the University of Chicago, Departments of Public Health Science (T.G.K., L.P.S., R.T.), Orthopaedic Surgery and Rehabilitation Medicine (D.R.D.), and Surgery (S.R.), Chicago, Illinois; and Northwestern University, Department of Preventive Medicine (M.K.), Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TA.0000000000002041DOI Listing
October 2018

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors.

J Clin Oncol 2018 06 13;36(16):1611-1618. Epub 2018 Feb 13.

Jason J. Luke, Jeffrey M. Lemons, Theodore G. Karrison, Sean P. Pitroda, James M. Melotek, Yuanyuan Zha, Hania A. Al-Hallaq, Ainhoa Arina, Nikolai N. Khodarev, Linda Janisch, Paul Chang, Jyoti D. Patel, Gini F. Fleming, John Moroney, Manish R. Sharma, Mark J. Ratain, Thomas F. Gajewski, Ralph R. Weichselbaum, and Steven J. Chmura, The University of Chicago, Chicago, IL; Julia R. White, The Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.2229DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978468PMC
June 2018

Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide.

Clin Cancer Res 2015 Nov 21;21(22):5092-9. Epub 2015 Jul 21.

Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois. Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, Illinois. Comprehensive Cancer Center, The University of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-15-0427DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677671PMC
November 2015

Building firm foundations for therapy development.

J Natl Cancer Inst 2015 Mar 20;107(3). Epub 2015 Feb 20.

Department of Public Health Sciences, University of Chicago (JJD, TGK).

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnc
Publisher Site
http://dx.doi.org/10.1093/jnci/djv016DOI Listing
March 2015

Identification of a variant in KDR associated with serum VEGFR2 and pharmacodynamics of Pazopanib.

Clin Cancer Res 2015 Jan 19;21(2):365-72. Epub 2014 Nov 19.

Program in Personalized and Genomic Medicine, and Division of Endocrinology, Diabetes and Nutrition, School of Medicine, University of Maryland, Baltimore, Maryland. Geriatric Research and Education Clinical Center, Baltimore Veterans Administration Medical Center, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1683DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323272PMC
January 2015

Resampling the N9741 trial to compare tumor dynamic versus conventional end points in randomized phase II trials.

J Clin Oncol 2015 Jan 27;33(1):36-41. Epub 2014 Oct 27.

Manish R. Sharma, Elizabeth Gray, and Theodore G. Karrison, University of Chicago, Chicago, IL; Richard M. Goldberg, Ohio State University, Columbus, OH; and Daniel J. Sargent, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.2826DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268251PMC
January 2015

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.

J Clin Oncol 2014 Sep 21;32(25):2735-43. Epub 2014 Jul 21.

Ezra E.W. Cohen, Theodore G. Karrison, Masha Kocherginsky, Jeffrey Mueller, Robyn Egan, Tanguy Y. Seiwert, Victoria M. Villaflor, Daniel J. Haraf, and Everett E. Vokes, University of Chicago, Chicago; Bruce E. Brockstein, North Shore University Health System, Evanston; Mark B. Agulnik and Bharat B. Mittal, Northwestern University, Chicago, IL; Chao H. Huang, University of Kansas and Veterans Affairs Medical Center, Kansas City, KS; Furhan Yunus and Sandeep Samant, University of Tennessee, Memphis, TN; Luis E. Raez, University of Miami, Miami, FL; Ranee Mehra, Fox Chase Cancer Center, Philadelphia, PA; Priya Kumar and Frank Ondrey, University of Minnesota, Minneapolis, MN; and Patrice Marchand and Bettina Braegas, Nuvisan Oncology, Le Kremlin-Bicêtre, France.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/07/18/JCO.2013.54
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.54.6309
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.54.6309DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876357PMC
September 2014

Quantitative allelic test--a fast test for very large association studies.

Genet Epidemiol 2013 Dec 1;37(8):831-9. Epub 2013 Nov 1.

Department of Health Studies, University of Chicago, Chicago, Illinois, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gepi.21768DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4054703PMC
December 2013

Estimation of progression-free survival in the randomized discontinuation trial design.

J Clin Oncol 2013 Feb 14;31(6):814. Epub 2013 Jan 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.46.1087DOI Listing
February 2013

Resampling phase III data to assess phase II trial designs and endpoints.

Clin Cancer Res 2012 Apr 27;18(8):2309-15. Epub 2012 Jan 27.

Departments of Medicine and Health Studies, University of Chicago, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-1815DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328614PMC
April 2012

Estimation of Progression-Free Survival for All Treated Patients in the Randomized Discontinuation Trial Design.

Am Stat 2012;66(3):155-162

Department of Health Studies, University of Chicago, 5841 S. Maryland Ave., MC2007, Chicago, IL 60637.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00031305.2012.720900DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769804PMC
January 2012

Outcomes in black patients with early breast cancer treated with breast conservation therapy.

Int J Radiat Oncol Biol Phys 2011 Feb 29;79(2):392-9. Epub 2010 Apr 29.

Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2009.11.017DOI Listing
February 2011

Phase II study of sunitinib malate in head and neck squamous cell carcinoma.

Invest New Drugs 2010 Oct 4;28(5):677-83. Epub 2009 Aug 4.

Section of Hematology-Oncology and Phase II network, University of Chicago Medical Center, S. Maryland Avenue, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-009-9296-7
Publisher Site
http://dx.doi.org/10.1007/s10637-009-9296-7DOI Listing
October 2010

Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia.

Invest New Drugs 2008 Jun 24;26(3):233-9. Epub 2008 Jan 24.

Section of Hematology/Oncology, Department of Medicine, University of Chicago Medical Center, 5841 S. Maryland Avenue, MC 2115, Chicago, IL 60637-1470, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-008-9115-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283497PMC
June 2008

Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.

J Natl Cancer Inst 2007 Oct 25;99(19):1455-61. Epub 2007 Sep 25.

Department of Health Studies, University of Chicago, Chicago, IL 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djm158DOI Listing
October 2007

A group sequential, response-adaptive design for randomized clinical trials.

Control Clin Trials 2003 Oct;24(5):506-22

Department of Health Studies, University of Chicago, Chicago, Illinois 60637, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0197-2456(03)00092-8DOI Listing
October 2003

The aspect ratio (dome/neck) of ruptured and unruptured aneurysms.

J Neurosurg 2003 Sep;99(3):447-51

Section of Neurosurgery and Department of Health Studies, University of Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://thejns.org/doi/10.3171/jns.2003.99.3.0447
Publisher Site
http://dx.doi.org/10.3171/jns.2003.99.3.0447DOI Listing
September 2003

Predictors of emergency medical services utilization by elders.

Acad Emerg Med 2003 Jan;10(1):52-8

Robert Wood Johnson Clinical Scholars Program, University of Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1553-2712.2003.tb01976.xDOI Listing
January 2003